Secrete growthfactors,cytokines and ECMcomponents that alter the properties of the microenvironment and promote tumour growth
Create a physicalbarrier around the tumour, which blocks immunecell and drugentry
Communicate with cancer cells to promote tumour survival
Cancer and stromal cells secrete TGF-beta, PDGF and fibroblastgrowthfactor in order to convert fibroblasts into cancerassociated fibroblasts (CAFs)
Describe the relationship between myofibroblast density and patient survival
Myofibroblast predicts clinicalprogression of cancer and therefore patientsurvivaltime. Higher densities of cancer associated fibroblasts relate to much poorer prognosis.
Describe the role of the ECM in TME
Sequester growth factors, which can be liberated later during ECM digestion, which generates localhighconcentrations and triggers growth signalling to cancer cells.
ECM can promoter tumour growth and progression
Create a physical barrier around the tumour, which blocks immune cell entry
Glycan modification can alter the structural properties of the matrix, which is implicated in cancer progression
Describe the importance of the stroma in the TME
The composition and functional state of tumour microenvironment affects cancer progression and treatment
For cancer to advance, it must manipulate cells in the TME, in order to metastasise.
Components of the tumour microenvironment vary by tissuetype and patient and coevolve with the tumour as it progresses.
What is heterotypic signalling?
This is communication between dissimilar cell types, such as cancer cells and stromal cells. Example:
Fibroblast Growth factor 10 ligand is secreted by stromal cells and binds to FGF receptors in cancer cells.
Stromal cells can secrete mitogenicgrowth factors, growthinhibitory signals and trophic factors.
Describe the different types of heterotypic cell communication